tradingkey.logo
tradingkey.logo
Search

Genmab A/S

GMAB
Add to Watchlist
28.870USD
+0.230+0.80%
Close 07-31 16:00ETQuotes delayed by 15 min
17.79BMarket Cap
21.75P/E TTM

GMAB Financials

See Genmab A/S's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Genmab A/S Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/0.34
Revenue / Forecast
3.31B/1.11B
Period
FY2025 Earnings
Revenue(YoY)
3.72B
19.19%
EPS(YoY)
1.55
-12.22%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
----
-72.55%0.08
-94.18%0.05
121.65%0.65
----
3.38%0.31
512.18%0.87
-38.28%0.29
5.46%0.32
543.81%0.30
30.95%0.14
--0.48
--0.30
--0.05
--0.11
----
----
----
----
----
----
Revenue
257.95%3.31B
25.31%896.00M
18.00%1.06B
28.22%1.02B
17.02%925.00M
19.58%715.00M
33.19%896.64M
18.50%797.06M
26.92%790.49M
43.04%597.95M
-8.00%673.22M
22.24%672.62M
43.35%622.82M
30.80%418.02M
86.33%731.80M
50.23%550.24M
36.07%434.47M
24.67%319.59M
19.94%392.75M
35.39%366.25M
----
Net Profit
----
-72.82%53.00M
-94.21%31.00M
120.15%401.00M
----
1.97%195.00M
481.14%535.25M
-39.66%182.15M
3.31%206.04M
517.37%191.23M
25.79%92.10M
-13.16%301.86M
-23.24%199.44M
-55.83%30.98M
-28.40%73.22M
146.35%347.62M
424.41%259.83M
-60.53%70.13M
9.87%102.26M
69.68%141.11M
----
Net Margin
----
-78.31%5.92%
-95.09%2.93%
71.70%39.24%
----
-14.35%27.27%
336.34%59.70%
-49.08%22.85%
-18.60%26.06%
329.70%31.84%
36.73%13.68%
--44.88%
--32.02%
--7.41%
--10.01%
----
----
----
----
----
----
Gross Margin
----
-1.47%92.75%
-2.56%92.34%
-0.79%94.32%
----
-1.46%94.13%
-2.61%94.77%
-2.88%95.07%
-3.03%96.48%
-4.48%95.52%
-2.69%97.31%
--97.89%
--99.50%
--100.00%
--100.00%
----
----
----
----
----
----
Debt to assets ratio
----
1891.32%43.24%
1776.52%42.15%
-18.73%2.02%
----
-21.15%2.17%
2.94%2.25%
10.59%2.49%
5.08%2.64%
0.95%2.75%
10.08%2.18%
--2.25%
--2.51%
--2.73%
--1.98%
----
----
----
----
----
----
Revenue
257.95%3.31B
25.31%896.00M
18.00%1.06B
28.22%1.02B
17.02%925.00M
19.58%715.00M
33.19%896.64M
18.50%797.06M
26.92%790.49M
43.04%597.95M
-8.00%673.22M
22.24%672.62M
43.35%622.82M
30.80%418.02M
86.33%731.80M
50.23%550.24M
36.07%434.47M
24.67%319.59M
19.94%392.75M
35.39%366.25M
----
Operating profit
----
19.68%225.00M
-15.22%260.00M
50.56%459.00M
----
62.62%188.00M
27.60%306.68M
25.23%304.87M
25.44%275.11M
87.95%115.61M
-34.48%240.33M
-6.36%243.44M
28.00%219.31M
-20.66%61.51M
220.62%366.82M
84.23%259.97M
34.46%171.34M
-10.13%77.52M
-19.48%114.41M
4.82%141.11M
----
Net Profit
----
-72.82%53.00M
-94.21%31.00M
120.15%401.00M
----
1.97%195.00M
481.14%535.25M
-39.66%182.15M
3.31%206.04M
517.37%191.23M
25.79%92.10M
-13.16%301.86M
-23.24%199.44M
-55.83%30.98M
-28.40%73.22M
146.35%347.62M
424.41%259.83M
-60.53%70.13M
9.87%102.26M
69.68%141.11M
----
Current assets
----
-36.26%2.57B
-25.60%2.88B
26.29%4.47B
24.05%3.91B
-18.83%4.04B
-20.97%3.88B
-24.41%3.54B
-27.72%3.15B
21.05%4.97B
20.79%4.91B
23.59%4.68B
21.34%4.36B
19.17%4.11B
16.85%4.06B
10.86%3.79B
11.00%3.59B
9.63%3.45B
12.70%3.48B
11.31%3.42B
12.19%3.24B
Total current liabilities
----
55.82%1.18B
93.12%1.43B
8.19%741.00M
0.32%629.00M
89.34%756.00M
100.92%738.92M
66.43%684.92M
114.62%627.02M
40.32%399.28M
40.14%367.77M
4.45%411.53M
6.59%292.15M
42.83%284.55M
9.46%262.43M
38.28%394.00M
27.23%274.08M
-2.33%199.22M
16.57%239.74M
-19.86%284.93M
-28.87%215.43M
Total assets
----
87.91%12.38B
101.86%12.87B
18.51%7.02B
16.49%6.46B
24.07%6.59B
22.06%6.38B
18.56%5.92B
18.37%5.55B
19.99%5.31B
20.50%5.22B
23.50%5.00B
21.01%4.69B
19.34%4.42B
15.15%4.34B
8.35%4.05B
8.05%3.87B
5.80%3.71B
8.50%3.77B
10.20%3.73B
14.97%3.59B
Total liabilities
----
418.91%6.69B
453.78%7.03B
9.87%1.27B
5.72%1.16B
113.10%1.29B
132.93%1.27B
97.56%1.16B
132.65%1.10B
29.81%605.35M
33.38%544.70M
10.13%585.10M
11.92%472.45M
42.80%466.34M
9.88%408.40M
26.37%531.26M
18.65%422.11M
-2.12%326.58M
11.99%371.68M
-12.32%420.39M
-16.09%355.75M
Total equity
----
7.29%5.68B
14.46%5.85B
20.60%5.75B
19.16%5.30B
12.61%5.30B
9.16%5.11B
8.08%4.77B
5.56%4.45B
18.83%4.70B
19.17%4.68B
25.52%4.41B
22.12%4.22B
17.08%3.96B
15.73%3.93B
6.06%3.51B
6.88%3.45B
6.63%3.38B
8.13%3.39B
13.91%3.31B
19.86%3.23B
Net operating income
----
-98.95%3.00M
-22.39%301.00M
79.00%536.00M
-71.60%62.00M
31.05%287.00M
60.74%387.85M
0.70%299.45M
242.69%218.34M
-53.03%219.00M
342.06%241.29M
11.53%297.36M
-53.63%63.71M
426.64%466.24M
47.28%54.58M
276.22%266.63M
139.06%137.42M
-53.92%88.53M
128.99%37.06M
-91.11%70.87M
1098.51%57.48M
Net investment
----
79.07%-9.00M
-47614.19%-5.57B
-263.67%-54.00M
102.05%26.00M
79.52%-43.00M
118.39%11.73M
-77.58%32.99M
-372.08%-1.27B
-11108.22%-210.00M
-241.99%-63.79M
178.59%147.15M
-224.90%-268.16M
98.14%-1.87M
60.36%-18.65M
27.15%-187.24M
-132.99%-82.54M
-7.16%-100.60M
58.86%-47.06M
36.14%-257.01M
84.42%250.16M
Net financing
----
-1261.54%-177.00M
1218674.76%5.23B
48.34%-21.00M
7.79%-406.00M
84.71%-13.00M
113.51%429.04K
-1492.42%-40.65M
-43142.15%-440.29M
3.48%-85.00M
-117.67%-3.17M
103.36%2.92M
103.34%1.02M
-812.30%-88.06M
630.17%17.97M
-2385.83%-86.98M
21.09%-30.66M
72.94%-9.65M
-53.46%2.46M
27.64%3.81M
-6681.73%-38.86M

FAQs

What is the total revenue of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its total revenue reached 3.72B, with a year-on-year change of 3.12B.

What are the current assets of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its current assets were 2.88B, with a year-on-year change of -26.03.

What are the total assets of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its total assets of Genmab A/S were 12.87B, with a year-on-year change of 100.70.

What are the total liabilities of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its total liabilities of Genmab A/S were 7.03B, with a year-on-year change of 450.20.

What is the total equity of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its total equity of Genmab A/S was 5.85B, with a year-on-year change of 13.82.

What is the net operating income of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its net operating income of Genmab A/S was 1.27B, with a year-on-year change of 23.59.

What is the net investment of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its net investment of Genmab A/S was -5.64B, with a year-on-year change of -289.98.

What is the net financing of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its net financing of Genmab A/S was 4.79B, with a year-on-year change of 946.11.

What is the Earnings Per Share (EPS) of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its Earnings Per Share (EPS) was 1.55, with a year-on-year change of -12.22.

What is the net income of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its net income was 963.00M, with a year-on-year change of -15.00.

What is the net margin of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its net profit margin was 25.89, with a year-on-year change of -28.69.

What is the gross margin of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its gross margin was 93.60, with a year-on-year change of -1.90.

What is the debt-to-asset ratio of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its debt-to-asset ratio was 42.15, with a year-on-year change of 1777.44.

What is the Return on Equity (ROE) of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its Return on Equity (ROE) was 17.53, with a year-on-year change of -24.03.

What is the Return on Assets (ROA) of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its Return on Assets (ROA) was 9.99, with a year-on-year change of -48.71.

What is the operating profit of Genmab A/S?

According to Genmab A/S's FY2025 earnings report, its operating profit was 1.27B, with a year-on-year change of 23.59.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.